¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È­"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • aging process
    ³ëÈ­°úÁ¤
  • agnogenic myeloid metaplasia
    ¿øÀκҸí°ñ¼öÈ­»ý
  • alcoholic cirrhosis
    ¾ËÄڿð£°æÈ­(Áõ)
  • alcoholization
    ¾ËÄÚ¿ÃÈ­
  • alimentary system
    ¼ÒÈ­°èÅë, ¼ÒÈ­°è
  • alimentary tract
    ¼ÒÈ­°ü
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • aliphatic hydrocarbon
    Áö¹æÁ·ÅºÈ­¼ö¼Ò
  • alkali burn
    ¾ËÄ®¸®È­»ó
  • alkalization
    ¾ËÄ®¸®È­
  • alkalizer
    ¾ËÄ®¸®È­Á¦
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • alkylation
    ¾Ëųȭ
  • allergization
    ¾Ë·¹¸£±âÈ­
  • alleviation
    ¿ÏÈ­, °æ°¨
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • morphea
    ±¹¼ÒÇǺΰæÈ­Áõ, ±¹¼ÒÇǺα»À½Áõ
  • matching
    1.¦Áþ±â, 2.Á¶È­, ÀÏÄ¡
  • masculinization
    ³²¼ºÈ­
  • mapping
    ÁöµµÈ­
  • malacia
    ¿¬È­(Áõ)
  • maceration
    Áþ¹«¸§, ¹°··È­
  • palliative medicine
    ¿ÏÈ­ÀÇÇÐ, °í½ÃÀÇÇÐ
  • squamous metaplasia
    ÆíÆò»óÇÇÈ­»ý
  • normalization
    Á¤»óÈ­, ±Ô°ÝÈ­
  • neurotropic
    ½Å°æÄ£È­-, Çâ½Å°æ-
  • neutralization
    ÁßÈ­
  • nitrification
    Áú»ê¿°È­, Áú»êÈ­
  • nitrogen dioxide
    ÀÌ»êÈ­Áú¼Ò
  • nephrosclerosis
    ÄáÆÏ±»À½Áõ, ½ÅÀå°æÈ­Áõ
  • carbon dioxide narcosis
    ÀÌ»êȭź¼ÒÈ¥¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • arteriosclerotic cardiovascular disease
    µ¿¸Æ°æÈ­½ÉÀåÇ÷°üº´
  • arteriosclerotic heart disease
    µ¿¸Æ°æÈ­½ÉÀ庴
  • assimilation product
    µ¿È­»ý»ê¹°
  • assimilation quotient
    µ¿È­À²
  • assimilation starch
    µ¿È­³ì¸»
  • assimilation starch grain
    µ¿È­³ì¸»°ú¸³
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • ataxic dysarthria
    Á¶È­¿îµ¿ºÒ´É¸»´õµëÁõ
  • ataxic dysphasia
    Á¶È­¿îµ¿¾ð¾îÀå¾Ö
  • ataxic gait
    Á¶È­¿îµ¿ºÒ´Éº¸Çà, Èçµé°ÉÀ½
  • ataxic hemiparesis
    Á¶È­¿îµ¿ºÒ´É¹ÝºÎÀü¸¶ºñ
  • ataxic nystagmus
    Á¶È­¿îµ¿ºÒ´É´«¶³¸², ¿îµ¿½ÇÁ¶´«¶³¸²
  • ataxic paraplegia
    Á¶È­¿îµ¿ºÒ´ÉÇϹݽŸ¶ºñ, Á¶È­¿îµ¿ºÒ´É¾çÃø¸¶ºñ
  • atherosclerotic plaque
    Á×»ó°æÈ­ÆÇ
  • atherosclerotic heart disease
    Á×»ó°æÈ­½ÉÀ庴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • adrenal virilism
    ºÎ½Å(¼º) ³²¼ºÈ­(¡­Ñûàõûù).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
  • aerification
    ±âÈ­(Ѩûù).
  • affinity
    ģȭ¼º
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúæ³)
  • affinity
    ģȭ¼º(öÑûúàõ), ģȭ·Â(öÑûúÕô), °áÇÕ¼º.
  • affinity
    ģȭ·Â, ģȭ¼º
  • affinity chromatography
    ģȭ(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
  • affinity chromatography
    ģȭ¼º Å©·Î¸¶Åä±×·¡ÇÇ
  • affinity coefficient
    ģȭ°è¼ö(öÑûúÌõâ¦)
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
  • agar streak method
    ÇÑõȭ¼±¹ý(¡­ûþàÊÛö).
  • age hardening
    ½ÃÈ¿°æÈ­(ãÁüùÌãûù).
  • age resister
    ³ëÈ­¹æÁöÁ¦(ÖÕûùÛÁò­ð¥).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • suppurative endophthalmitis
    È­³ó¾È³»¿°, È­³ó´«¼Ó¿°Áõ
  • ophthalmoblenorrhea
    È­³ó¾È¿°
  • purulent ophthalmia
    È­³ó¾È¿°
  • pyophthalmitis
    È­³ó¾È¿°
  • suppurantia =pustulantia
    È­³ó¾à(ûùÒÛå·).
  • ecpyetic
    È­³óÃËÁø(È­³óÃËÁø)ÀÇ.
  • suppurative iridocyclitis
    È­³óȫä¸ð¾çü¿°
  • suppurative iritis
    È­³óȫä¿°
  • heating power
    È­·Â(Ì´Ëç).
  • heating power
    È­·Â(ûýæ³).
  • frame rate
    È­¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
  • scroll
    È­¸é À̵¿
  • frame rate
    È­¸éÀ²
  • stoker s cramp
    È­ºÎ°æ·Ã(ûýÜýÌâÕý)
  • fireman s cramp
    È­ºÎ°æ·Ã(ûýÜýÌâÕý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • anabolic steroid
    ´Ü¹éµ¿È­½ºÅ×·ÎÀ̵å.
  • anabolism
    µ¿È­(ÀÛ¿ë)(ÔÒûùíÂéÄ)
  • analytical chemistry
    ºÐ¼®È­ÇÐ(ÝÂà°ûùùÊ).
  • analytical chemistry
    ºÐ¼®È­ÇÐ
  • anamnestic
    ±â¾ï°­È­¼ºÀÇ.
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
  • angiokeratoma
    °¢È­Ç÷°üÁ¾(ÊÇûùúìηðþ), ¸Æ°ü°¢È­Áõ(ØæÎ·ÊÇûùñø)
  • angiokeratoma
    °¢È­Ç÷°üÁ¾(ÊÇûùúìηðþ), ¸Æ°ü°¢È­Áõ(ØæÎ·ÊÇûùñø)
  • angiokeratoma circumscriptum
    ±¹ÇѼº °¢È­Ç÷°üÁ¾
  • angiokeratoma corporis
    ±¸°£°¢È­Ç÷°üÁ¾(ÏÆÊÏÊÇûùúìηðþ)
  • angiokeratoma corporis diffusum
    Àü½Å¼º ±¸°£°¢È­Ç÷°üÁ¾(îïãóàõÏÆÊÏÊÇûùúìηðþ)
  • angiokeratoma of Fordyce
    Æ÷´ÙÀ̽º Ç÷°ü °¢È­Á¾(úìη ÊÇûùðþ)
  • angiokeratoma of Mibelli
    ¹Ìº§¸® Ç÷°ü °¢È­Á¾(úìη ÊÇûùðþ)
  • angiosclerosis
    Ç÷°ü°æÈ­(Áõ)
  • angiosclerotic necrosis
    Ç÷°ü°æÈ­¼º ±«»ç.
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • randomization
    ¹«ÀÛÀ§È­
    ÙííÂêÓûù
  • rarefaction
    <-> condensation(ÀÀÃà) Èñ¹ÚÈ­
    ýüÚÝûù
  • reactivation
    ÀçȰ¼ºÈ­
    î¢üÀàõûù
  • redifferentiation
    ÀçºÐÈ­
    î¢ÝÂûù
  • reinforcement
    °­È­
    Ë­ûù
  • remission
    ¿ÏÈ­
    èÐûú
  • reticulation
    ±×¹°È­, ¸Á»óÈ­
    ±×¹°ûù, ØÑßÒûù
  • sclerosis
    ±»À½, °æÈ­
    Ìãûù
  • ¤Ñ CT
    ¾ÈÀåÀü»êÈ­´ÜÃæÃÔ¿µ
    äÓíûï³ß©ûùÓ¨öµõÉç¯
  • SjVO2, jugular venous oxygen saturation
    °æÁ¤¸Æ»ê¼ÒÆ÷È­µµ
    Ìòð¡Øæß«áÈøéûúÓø
  • Superoxide
    °ú»êÈ­¹°
    Φ߫ûùÚª
  • alimentary s.
    ¼ÒÈ­°è
    á¼ûùͧ÷Ö
  • digestive s.
    ¼ÒÈ­°è
    á¼ûùͧ÷Ö
  • quantifiable t.
    Á¤·®È­°Ë»ç
    ïÒÕáûù ËþÞÛ
  • tuberous sclerosis
    °áÀý°æÈ­Áõ
    Ì¿ï½àõÌãûùñø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • double lysogeny
    ÀÌÁß ¿ë¿øÈ­(ì£ñì éÁê«ûù)
  • dye-sensitized photooxidation
    »ö¼Ò °¨¼ö¼º ±¤»êÈ­(ßäáÈÊïáôàõÎÃß«ûù)
  • eclosion hormone
    ¿ìÈ­(éâûù) È£¸£¸ó
  • ectchemistry
    Ç¥¸éÈ­ÇÐ(øúØüûùùÊ)
  • efflorescence
    dzȭ(ù¦ûù)
  • elaidinization
    ÀÏ·¹À̵òÈ­(ûù)
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§(ï³Ñ¨ûùùÊï³êÈ)
  • electromechanochemical coupling hypothesis
    Àü±â±â°èÈ­ÇÐÀû(ï³Ñ¨Ñ¦ÌþûùùÊîÜ) ¦Áþ±â¼³(àã)
  • electron affinity
    "ÀüÀÚ Ä£È­¼º(ï³í­öÑûúàõ)(µµ,Óø)"
  • electron ionization mass spectrometry
    ÀüÀÚ(ï³í­)ÀÌ¿ÂÈ­(ûù) Áú·® ºÐ¼®¹ý(òõÕáÝÂà°Ûö)
  • emulsification
    ¿¡¸ÖÁ¯È­(ûù)
  • emulsifying agent
    ¿¡¸ÖÁ¯È­Á¦(ûùð¥)
  • energy of activation
    Ȱ¼ºÈ­(üÀàõûù) ¿¡³ÊÁö
  • energy-poor compound
    ºó(Þ¸)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • energy-rich compound
    ºÎ(Ý£)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • localization
    ±¹¼ÒÈ­, ±¹Àç(È­), Á¤À§, À§Ä¡°áÁ¤
  • longitudinal magnetization
    Á¾ÃàÀÚÈ­
  • lumbarization
    ¿äÃß°ñÈ­, ¿äÃßÈ­
  • luteinization
    Ȳüȭ
  • luteinizing hormone
    Ȳüȭȣ¸£¸ó, ȲüÇü¼ºÈ£¸£¸ó
  • magnetic moment nulling
    ÀÚ±â¸ð¸àÆ®¹«È¿È­
  • magnetic saturation
    ÀÚ±âÆ÷È­
  • magnetic susceptibility
    ÀÚ±âÈ­À²
  • magnetic susceptibility artefact
    ÀÚ±âÈ­À²Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²°æ»ç
  • magnetic susceptibility variation
    ÀÚ±âÈ­À²º¯ÀÌ
  • magnetic transfer contrast [=MTC]
    ÀÚÈ­Àü´Þ´ëÁ¶µµ
  • magnetisation transfer coherence
    ÀÚÈ­Àü´Þ°áÁý
  • magnetizability
    ÀÚÈ­´É
  • magnetization
    ÀÚÈ­, ÀÚ±âÈ­
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • H66.4
    Suppurative otitis media, unspecified
    »ó¼¼ºÒ¸íÀÇ È­³ó¼º ÁßÀÌ¿°
  • H74.0
    Tympanosclerosis
    °í½Ç°æÈ­Áõ
  • H80
    Otosclerosis
    ±Í°æÈ­Áõ
  • H80.0
    Otosclerosis involving oval window, non- obliterative
    ³­¿øÃ¢À» ħ¹üÇÏ´Â ºñÆó»ö¼º ±Í°æÈ­Áõ
  • H80.1
    Otosclerosis involving oval window, obliterative
    ³­¿øÃ¢À» ħ¹üÇÏ´Â Æó»ö¼º ±Í°æÈ­Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium oxide
    »êÈ­ Ä®½·
    ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êȭź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
  • calcium pyrophosphate dihydrate
    À̼öÈ­ ÇÇ·ÎÀλê Ä®½·
  • calgon
    °æ¼ö ¿¬È­Á¦
  • calibration curve
    º¸Á¤ °î¼±, Ç¥ÁØÈ­ °î¼±
  • CAM 1. ÈÄÀ±»ó ÇÇ¿­±Ù. 2. ¸¸¼º À¯Âø °úÁ¤.

    camabrasion

    È­ÇÐ ¿¬¸¶
    Ç¥ÇÇ¿Í ÁøÇÇ »óÃþÀÇ Ç¥Ãþ ÆÄ±«¸¦ ÀÏÀ¸Å³ ¸ñÀûÀ¸·Î, ÇǺο¡ ºÎ½ÄÁ¦¸¦ Àû¿ëÇÏ´Â °Í. ¹ÝÈç, ÀÚû, ¸ð¹Ý, °¡´Â ÁÖ¸§»ì µîÀ» Á¦°ÅÇϱâ À§ÇØ ½ÃÇàÇÑ´Ù.
  • canceration
    ¾ÏÈ­, ¾Ï ¹ß»ý
    ¾ÏÀÇ º¯Çü.
  • carbide
    źȭ¹°
    ¿ø¼Ò ¶Ç´Â ±â¿Í °áÇÕÇÑ È­ÇÕ¹°.
  • carbohydrate
    ´çÁú, ź¼öÈ­¹°
    ´Ù°¡ ¾ËÄÝ, ƯÈ÷ 5°¡ ¹× 6°¡ ¾ËÄÝÀÇ ¾Ëµ¥ÇÏÀ̵å ȤÀº Űſ À¯µµÃ¼ ¼ö¼Ò¿Í »ê¼Ò°¡ º¸Åë ¹°°ú °°Àº ºñÀ²·Î ÇÔÀ¯µÇ¹Ç·Î
  • carbohydrate fermentation test
    ź¼öÈ­¹° ¹ßÈ¿ ½ÃÇè
  • carbohydrate metabolism disorder
    ź¼öÈ­¹° ´ë»ç Àå¾Ö
  • carbohydrate tolerance
    ź¼öÈ­¹° ºÎÇÏ, ź¼öÈ­¹° ³»Àμº
  • carbohydrate utilization test
    ź¼öÈ­¹° ÀÌ¿ë ½ÃÇè
  • carbon dioxide
    ÀÌ»êȭź¼Ò, ź»ê °¡½º
    1. ¹«Ãë, ¹«»öÀÇ ±âü. ź¼Ò¸¦ »êÈ­ÇÏ¿© ¾ò´Â´Ù. Á¶Á÷¿¡¼­ Çü¼ºµÇ¾î Æó·Î ¹èÃâµÈ´Ù. ÀÌ»êȭź¼Ò¿Í ź»ê¿°Àº ½Åü Á¶Á÷°ú ü¾×ÀÇ Áß¼ºÀ» À¯ÁöÇÏ´Â °ÍÀ» Á¶ÀýÇÏ´Â ÀÛ¿ëÀ» ÇÑ´Ù. 5-7% ź»ê °¡½º¸¦ ÇÔÀ¯ÇÏ´Â »ê¼Ò È¥ÇÕ¹° ÇüÅ·ΠȣÈíÀ» ÀÚ±ØÇϴµ¥ »ç¿ëµÇ°í ±×¿Ü °íüÇüÀ¸·Î ¾î¶² Á¾·ùÀÇ ÇǺκ´ Ä¡·á¿¡µµ »ç¿ëµÈ´Ù. 2. »ýü¿¡ ÀÇÇØ »ê¼Ò¿Í ¿µ¾ç¼Ò°¡ °áÇÕÇÒ ¶§ »ý»êµÇ´Â °¡½º¼º ³ëÆó¹°.
  • carbon dioxide narcosis
    ÀÌ»êȭź¼Ò È¥¹ÌÁõ
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • dartist
    È­»ì´øÁö±â °ÔÀÓÀ» ÇÏ´Â »ç¶÷
  • arrowy
    È­»ìÀÇ;ºü¸¥
  • bowshot
    È­»ìÀÌ´ê´Â°Å¸®;»çÁ¤°Å¸®
  • Sagitta
    È­»ìÀÚ¸®(the Arrow)
  • arrowhead
    È­»ìÃË
  • sagittate
    È­»ìÃË ¸ð¾çÀÇ
  • flinthead
    È­»ìÃË(ºÎ½Ëµ¹·Î ¸¸µç)
  • arrowhead
    È­»ìÃË;¼è±Í³ª¹«¼ÓÀÇ ½Ä¹°
  • fossil
    È­¼®
  • zoolite
    È­¼® µ¿¹°
  • taphonomy
    È­¼® »ý¼º(·Ð)
  • fossil fuel
    È­¼® ¿¬·á(¼®À¯,¼®Åº,õ¿¬ °¡½º µî)
  • fossilize
    È­¼®À¸·Î ¸¸µé´Ù;È­¼® äÁýÀ» ÇÏ´Ù;½Ã´ë¿¡ µÚÁö°Ô ÇÏ´Ù
  • fossiliferous
    È­¼®À» ÇÔÀ¯ÇÑ
  • scatology
    È­¼®ÀÇ ºÐ¼®ÇÐ. ¿Ü¼³¹®ÇÐ.
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • difficulty
    °ï¶õ,ºÒÈ­,³­±¹
  • digest
    ¼ÒÈ­ÇÏ´Ù; Å͵æÇÏ´Ù; Àû¿ä; ¿ä¾à
  • dihydr
    ¼ö¼Ò¿ÍÀÇ È­ÇÕ¹°ÀÎ
  • dihydro
    ¼ö¼Ò¿ÍÀÇ È­ÇÕ¹°ÀÎ
  • dime
    (¹Ì±¹,ij³ª´Ù)10¼¾Æ® ÀºÈ­
  • discord
    ºÒÀÏÄ¡; ºÒÈ­
  • discordance
    ºÎÁ¶È­
  • discordancy
    ºÎÁ¶È­
  • discordant
    Á¶È­ÇÏÁö ¾Ê´Â
  • discourse
    ´ãÈ­
  • disorder
    ºÎÁ¶È­
  • dissonance
    ºÒÇùÈ­À½
  • dissonancy
    ºÒÇùÈ­
  • disulfide
    ÀÌȲȭ¹°
  • disulphide
    ÀÌȲȭ¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á